A detailed history of Ti Trust, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ti Trust, Inc holds 22,637 shares of BMY stock, worth $1.2 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
22,637
Previous 22,637 -0.0%
Holding current value
$1.2 Million
Previous $1.23 Million 23.39%
% of portfolio
0.72%
Previous 0.9%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

BUY
$57.89 - $64.73 $5,152 - $5,760
89 Added 0.39%
22,637 $1.31 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $5,585 - $6,335
85 Added 0.38%
22,548 $1.56 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $48 - $28,815
375 Added 1.7%
22,463 $1.6 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $1.09 Million - $1.42 Million
22,088 New
22,088 $1.42 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ti Trust, Inc Portfolio

Follow Ti Trust, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ti Trust, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ti Trust, Inc with notifications on news.